US President Donald Trump on Monday announced nine more agreements with pharmaceutical manufacturers intended to lower prescription drug prices nationwide, bringing the total to 26, but patient advocates responded skeptically. The…
Page F3From§Eachthe early evening edition — 31 August 2026
Supreme Court Clears Trump's Ballroom Construction; His Pharma Deals Called A Failed Drug Price Plan

As it ran on the front
I ran two receipts against each other today, hon, because they landed in the same news cycle and that is exactly when reconciliation earns its keep. Receipt one: the Supreme Court, this week, continues to allow construction of the White House ballroom to proceed. Receipt two: the administration's pharmaceutical agreements, the ones sold as the answer to drug prices, are being described, on the record, as a distraction from a failed plan to lower those prices. Both receipts describe the same administration, in the same month, on two different ledgers — one for concrete and marble, one for prescriptions.
I don't file motives. I file what's built and what's promised. What's built: a ballroom, cleared by the highest court in the country to keep rising. What's promised, going back years now: lower drug prices, delivered this time through negotiated pharma deals. What the ledger shows: the building proceeds on schedule; the pricing promise is being called, by people who track that promise for a living, a failed plan wearing a press release.…
…(cont) I want to be careful with the word 'failed,' because I don't use adjectives I can't source. That word isn't mine — it's the description already attached to the plan in its own coverage. My job is just to notice where it sits on the calendar: the same season the ballroom clears its last legal hurdle. A household budget with one line item cleared for construction and another line item quietly marked failed usually tells you which project the household actually prioritized, whether or not the household says so out loud.
I'll also note, because the ledger asks it: nobody in either receipt disputes that the ballroom is moving forward. Nobody in either receipt disputes that the drug price plan hasn't delivered lower drug prices. Those are the two facts sitting next to each other on the same page today, and reconciliation isn't more complicated than noticing that one of them got a court order and the other got a correction.
I don't say where the money should go instead. I just note that this week, one thing that was optional got cleared, and one thing that was promised to every person paying for a prescription got called a failure. File that under priorities and move to the next drawer.
“One hand pours concrete for a ballroom nobody asked for, the other hand can't get insulin below list price after promising it for a decade. That's not two separate stories, that's the household budget of the country laid out in one afternoon. Somebody's paying for both projects — it's just not the same somebody who's building it.”
“The ballroom is privately funded, most of it, of course — did I say privately? I mean, there's public land under it, technically, but that's just siting, not spending. And the pharma deals — historic, frankly, just not measured in the metric where prices actually go down, but that's a whole separate conversation.”
The receipts
The Supreme Court divided 5-4 in allowing construction of the new White House ballroom to continue.
This page is a back-issue: the story as it ran, receipts as they were. The current edition is at the front.